Immunotherapy and Targeted Molecular Therapies for Parkinson's Disease in Under-Resourced Settings

Parkinson's disease presents a growing global health challenge, particularly in under-resourced settings where access to specialized care and advanced therapies remains limited. This book explores the evolution and innovation of Parkinson's disease therapies, examining historical developments, current treatment standards, and emerging strategies adapted for resource-constrained environments. Emphasis is placed on cost-effective pharmacological approaches, technological innovations, community-based interventions, and sustainable care models. By highlighting challenges, opportunities, and future directions, the book aims to promote equitable access to effective Parkinson's disease management and support the development of inclusive, patient-centered healthcare systems worldwide.